Kiromic BioPharma, Inc. (KRBPQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Mar 3, 2026, 4:00 PM EST
Kiromic BioPharma Market Cap
Kiromic BioPharma has a market cap or net worth of $16 as of March 4, 2026. Its market cap has decreased by -100.00% in one year.
Market Cap
16.00
Enterprise Value
13.43M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since October 16, 2020, Kiromic BioPharma's market cap has decreased from 84.33M to 16.00, a decrease of -100.00%. That is a compound annual growth rate of -94.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 16.00 | 700.00% |
| Dec 30, 2025 | 2.00 | -100.00% |
| Dec 31, 2024 | 1.38M | 26.04% |
| Dec 29, 2023 | 1.09M | -66.79% |
| Dec 30, 2022 | 3.30M | -86.04% |
| Dec 31, 2021 | 23.62M | -61.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tengion | 40.00 |
| Claritas Pharmaceuticals | 38.00 |
| Neurobiological Technologies | 27.00 |
| TetraLogic Pharmaceuticals | 24.00 |
| Verde Science | 24.00 |
| Sienna Biopharmaceuticals | 23.00 |
| IMV Inc. | 15.00 |
| PhaseRx | 12.00 |